4th Quarter - Report

AVENUE SOLUTIONS for JAZZ PHARMACEUTICALS, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

PL 114-255, 21st Century Cures Act, implementation; H.R. 4784, Lower Drug Costs Through Competition Act; S. 974/H.R. 2212, CREATES Act of 2015; H.R. 2051, FAST Generics; Drug safety issues; Prescription drug abuse; Issues related to opioids policies and offsets; H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT for Patients and Communities Act); S. 3120, Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 (HEAL Act of 2018); S. 2680, Opioid Crisis Response Act of 2018

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2212 (115th), H.R. 6 (115th), S. 3120 (115th), H.R. 4784 (115th), S. 974 (115th), S. 2680 (115th), H.R. 2051 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.